Stay updated on Preventing GvHD in Allo ApoGraft SCT - Clinical Trial
Sign up to get notified when there's something new on the Preventing GvHD in Allo ApoGraft SCT - Clinical Trial page.

Latest updates to the Preventing GvHD in Allo ApoGraft SCT - Clinical Trial page
- Check6 days agoChange DetectedThe record history now lists Revision: v3.5.3, indicating an updated version of the study record metadata.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRevision v3.5.2 was added to the history and Revision v3.5.0 was removed.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check49 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0 on the site; no user-visible content or data changes are indicated in the screenshot.SummaryDifference0.1%

- Check56 days agoChange DetectedRevision history adds Revision: v3.4.3 and removes Revision: v3.4.2.SummaryDifference0.1%

- Check84 days agoChange DetectedRevision: v3.4.2 was added to the history, and the older funding notice and revision v3.4.1 were removed.SummaryDifference0.8%

- Check91 days agoChange DetectedA site-wide notice regarding government funding was added and the revision history shows a new revision v3.4.1, with the previous v3.4.0 entry removed.SummaryDifference0.8%

Stay in the know with updates to Preventing GvHD in Allo ApoGraft SCT - Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Preventing GvHD in Allo ApoGraft SCT - Clinical Trial page.